What is Theravance Biopharma's total revenue?

Theravance Biopharma (TBPH) reported total revenue of $17.7M in Q1 2026.

How has Theravance Biopharma's total revenue changed year-over-year?

Theravance Biopharma's total revenue increased by 15.0% year-over-year, from $15.39M to $17.7M.

What is the long-term trend for Theravance Biopharma's total revenue?

Over 4 years (2021 to 2025), Theravance Biopharma's total revenue has grown at a 18.1% compound annual growth rate (CAGR), from $55.31M to $107.46M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Theravance Biopharma TBPH Total Revenue

Total Revenue at other companies

Zevra Therapeutics, Inc.ZVRA

$36.22M+77.5%

LQD

Liquidia CorporationLQDA

$132.87M+4,158%

Royalty PharmaRPRX

$630.58M+11.0%

United TherapeuticsUTHR

$781.5M-1.6%

Aurinia PharmaceuticalsAUPH

$77.71M+24.4%

PrecigenPGEN

$23.25M+1,634%

Segments

By segment

See full

Single Reportable$17.7M+15.0%

By geography

See full

Europe$223K—

Other financials

Income statement

See full

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's total revenue?: Theravance Biopharma (TBPH) reported total revenue of $17.7M in Q1 2026.
How has Theravance Biopharma's total revenue changed year-over-year?: Theravance Biopharma's total revenue increased by 15.0% year-over-year, from $15.39M to $17.7M.
What is the long-term trend for Theravance Biopharma's total revenue?: Over 4 years (2021 to 2025), Theravance Biopharma's total revenue has grown at a 18.1% compound annual growth rate (CAGR), from $55.31M to $107.46M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.